Colgate-Palmolive Company CL delivered mixed results for fourth-quarter 2024. While the company's earnings exceeded the Zacks Consensus Estimate, its revenues fell short of expectations. Despite the ...

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...

Colgate-Palmolive is a high-quality business with consistent revenue growth, stable gross profit margins, and a strong return on invested capital, making it a solid dividend stock. The company has an ...

Oral care major Colgate-Palmolive India is sharpening its focus on premiumisation as urban markets show early signs of recovery, industry executives in the know said. At the same time, the consumer ...